CME rallies as strong earnings and shareholder returns attract buyers

Traders Union
All News
Stocks
CME Group jumps 3.48% to $306

Highlights

CME Group posted record third-quarter 2026 revenue of $1.74 billion, exceeding analyst expectations for the period.
Net income reached $1.04 billion with diluted earnings per share of $2.89, and the company returned nearly $1 billion to shareholders through dividends and buybacks.
Shares of CME trade in a bullish trend with strong buyer momentum indicators; the short-term expected price range is $301.03 to $310.67.

Record revenue and capital returns bolster bullish investor sentiment

CME Group reported record third-quarter 2026 revenue of $1.74 billion, surpassing analyst expectations and signaling robust demand for its core trading services. Profitability remains strong with net income reaching $1.04 billion and diluted earnings per share of $2.89, confirming the company's financial strength. Additionally, CME Group returned nearly $1 billion to shareholders through a combination of $465 million in dividends and $524 million in share repurchases, according to Quiverquant, providing further incentive for investor participation.

Overbought signals as buying momentum aligns with technical support

On the hourly chart, CME is trading above the MA-20 ($295.62) and MA-50 ($290.17), while the daily chart shows it holding above the MA-200 ($279.02). Immediate support is located at the Ichimoku Kijun level of $298. Momentum is confirmed by both MACD and ADX, which indicate continued buying strength. Meanwhile, RSI, CCI, Stochastic RSI, and Bull/Bear Power all signal overbought conditions, highlighting heightened intraday demand. The Awesome Oscillator remains neutral, suggesting some divergence among oscillators.

Upside bias prevails amid range-bound short-term outlook

In the short term, CME is expected to consolidate within a typical volatility band between $301.03 and $310.67. The probability of an upside attempt to challenge or exceed range highs is very high, while downside risk becomes more likely if the price falls below $301.03. The baseline scenario is for price action to remain confined to this range over the next several sessions.

Anton Kharitonov, expert at Traders Union, sees strong technical momentum following CME Group’s record revenue and robust capital returns. He notes that while indicators confirm demand and outperformance, overbought signals and a tight trading range suggest caution is warranted. The analyst remains defensive as long as price holds above $301.03, but sees upside attempts as likely. "Base case remains rangebound with upside tests favored — but I will only turn constructive if price establishes support above $310.67."

Previously it was reported that CME Group delivered record quarterly results and maintained a broadly bullish price structure. The latest earnings beat and robust capital returns reinforce the company's strong positioning, with price action warranting particular attention to any sustained moves beyond the current $301.03–$310.67 consolidation range.

Source of Data: CME Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.